FDA approves First Scorpion Sting Antidote!

The Food and Drug Administration (FDA) has just approved the first treatment specifically for the sting of the Centruroides scorpion, the most common type in the United States. The new biologic treatment—called Anascorp—was given a priority review because adequate treatment did not exist in the United States, says Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research.

“This product provides a new treatment for children and adults and is designed specifically for scorpion stings,” Midthun says. “Scorpion stings can be life-threatening, especially in infants and children.”

Source: FDA Consumer Updates page

Link 1